It wasn’t a popular idea at the outset. Amy Abernethy, MD, PhD, and her colleagues suggested a decade ago that patients nearing the end of life could stop at least some of their medications. But their attempts to publish material on the subject initially met with resistance. “There was great angst among reviewers about medication discontinuation of any kind,” she said of a commentary they eventually published in BMJ (Stevenson J et al. BMJ. 2004;329:909-912). “They felt it would be equivalent to saying to a patient, ‘You’re not worthy to be on this medication.’”
Graham J. End-of-Life Medications Draw More Attention, Greater Scrutiny. JAMA. 2015;313(3):231–233. doi:10.1001/jama.2014.17360
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: